Search bioRxiv⌕ Search

Biology subjects

Drouet, A.

Publications and source records attributed to Drouet, A..

2 recordsLinked to original sources

High-affinity detection of endogenously biotinylated neuroligin-1 at excitatory and inhibitory synapses using a tagged knock-in mouse strain

Neuroligins (NLGNs) are important cell adhesion molecules mediating trans-synaptic contacts between neurons. However, the high-yield biochemical isolation and visualization of endogenous NLGNs have been hampered by the lack of efficient antibodies to these proteins. Thus, to reveal their sub-cellular distribution, binding partners, and synaptic function, NLGNs have been extensively manipulated using knock-down, knock-out, or over-expression approaches, overall leading to controversial results. As an alternative to the manipulation of NLGN expression level, we describe here the generation of a new transgenic mouse strain in which native NLGN1 was N-terminally tagged with a small biotin acceptor peptide (bAP) that can be enzymatically biotinylated by the exogenous delivery of biotin ligase. After showing that knock-in mice exhibit normal behavior as well as similar synaptic number, ultrastructure, transmission properties, and protein expression levels when compared to wild type counterparts, we exploited the fact that biotinylated bAP-NLGN1 can be selectively isolated or visualized using high-affinity streptavidin conjugates. Using immunoblotting and immunofluorescence, we show that bAP-NLGN1 binds both PSD-95 and gephyrin and distributes equally well at excitatory and inhibitory synapses, challenging the historical view that NLGN1 is exclusively localized at excitatory synapses. Using super-resolution fluorescence microscopy and electron microscopy, we further highlight that bAP-NLGN1 forms in the synaptic cleft a subset of nanodomains each containing a few NLGN1 dimers, while the number of nanodomains per synapse positively scales with the post-synapse size. Overall, our study not only provides a novel, extensively characterized transgenic mouse model which will be made available to the scientific community, but also an unprecedented view of the nanoscale organization of endogenous NLGN1.

neuroscience↗

Disequilibrium between BRCA1 and BRCA2 circular and messenger RNAs plays a role in breast cancer

AO_SCPLOWBSTRACTC_SCPLOWBreast cancer is a frequent disease for which the discovery of markers for early detection or prognostic assessment remains challenging. Circular RNAs (circRNAs) are single-stranded structures in closed loops, produced by backsplicing. CircRNA and messenger RNA (mRNA) are generated cotranscriptionally and backsplicing and linear splicing compete against each other. As mRNAs are key players in tumorigenesis, we hypothesize that a balance disruption between circRNAs and mRNAs could promote breast cancer. Hence, we developed an assay for a simultaneous study of circRNAs and mRNAs, called Splice and Expression Analyses by exon Ligation and High Throughput Sequencing (SEALigTHS). Following SEALigHTS validation for BRCA1 and BRCA2, our hypothesis was tested using an independent research set of 95 pairs of tumour and adjacent normal breast tissues. On this research set, ratios of BRCA1 and BRCA2 circRNAs/mRNAs were significantly lower in tumour breast tissue compared to normal tissue (p=1.6e-09 and p=4.4e-05 for BRCA1 and BRCA2, respectively). Overall, we developed an innovative method to study linear and backsplicing, described the repertoire of BRCA1 and BRCA2 circRNAs, including 10 novel ones, and showed for the first time that a disequilibrium between BRCA1 and BRCA2 circRNAs and mRNAs plays a role in breast cancer.

cancer biology↗